| dbo:abstract
|
- Cell Signaling Technology ist ein US-amerikanischer Hersteller von polyklonalen und monoklonalen Antikörpern für die Grundlagenforschung, die weltweit vertrieben werden. Der Produktfokus liegt im Bereich der post-translationale Proteinmodifikationen, der Signaltransduktion und v. a. phospho-spezifischen Antikörpern. (de)
- Cell Signaling Technology, Inc. (CST) is a privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health. CST maintains an in-house research program, particularly in the area of cancer research, and has published scientific papers in many peer-reviewed journals. (en)
|
| dbo:foundingYear
| |
| dbo:industry
| |
| dbo:location
| |
| dbo:numberOfEmployees
|
- 500 (xsd:nonNegativeInteger)
|
| dbo:product
| |
| dbo:thumbnail
| |
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 6567 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:foundation
| |
| dbp:founder
| |
| dbp:homepage
| |
| dbp:industry
| |
| dbp:keyPeople
|
- Michael Comb, President and CEO, Roberto Polakiewicz, CSO, Matthew Curran, CFO, Paul Aldridge, CDO, John Letcher, SVP HR, Benjamin Comb, SVP Corporate Strategy, Simona Levi, General Counsel, Corporate Secretary, Craig Thompson, VP Global Operations (en)
|
| dbp:location
| |
| dbp:logo
|
- Logo CellSignalingTechnology.gif (en)
|
| dbp:logoSize
| |
| dbp:name
|
- Cell Signaling Technology, Inc. (en)
|
| dbp:numEmployees
| |
| dbp:products
|
- Antibodies, ELISA Kits, ChIP Kits, Proteomics kits (en)
|
| dbp:subsid
|
- Cell Signaling Technology Limited (en)
- Cell Signaling Technology Europe, B.V. (en)
- Cell Signaling Technology Japan, K.K. (en)
|
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| schema:sameAs
| |
| rdf:type
| |
| rdfs:comment
|
- Cell Signaling Technology ist ein US-amerikanischer Hersteller von polyklonalen und monoklonalen Antikörpern für die Grundlagenforschung, die weltweit vertrieben werden. Der Produktfokus liegt im Bereich der post-translationale Proteinmodifikationen, der Signaltransduktion und v. a. phospho-spezifischen Antikörpern. (de)
- Cell Signaling Technology, Inc. (CST) is a privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health. CST maintains an in-house research program, particularly in the area of cancer research, and has published scientific papers in many peer-reviewed journals. (en)
|
| rdfs:label
|
- Cell Signaling Technology (de)
- Cell Signaling Technology (en)
|
| owl:sameAs
| |
| skos:closeMatch
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Cell Signaling Technology, Inc. (en)
|
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
